NAGAILEBEN Co.,Ltd. (7447) Stock Price

Nagaileben is a company primarily engaged in the planning, manufacturing, and sales of various medical apparel for healthcare and care workers, as well as shoe sales. The company designs and develops products in-house, which are then produced by manufacturing subsidiaries, and sells both domestically and internationally produced goods.

The company's main customers are healthcare and care workers at hospitals, clinics, and care facilities. Revenue is centered on the sales of uniforms and practical work clothing. Sales channels include both direct sales and sales through business partners, with product sales accounting for the majority of revenues.

The business is concentrated in a single segment: the manufacturing and sales of medical apparel and related products. The product lineup centers on medical uniforms and care worker clothing, and includes domestically and internationally produced goods sourced from manufacturing subsidiaries and general business partners, as well as externally sourced shoes.

The company has positioned improving operating profit margin on sales and return on equity (ROE) as key long-term management objectives. For the fiscal year ending August 2026, the company targets sales of 18.0 billion yen, representing a 6.0% increase year-over-year. While the healthcare sector environment is expected to improve due to factors such as revisions to medical reimbursement rates, the company anticipates headwinds from rising raw material costs, logistics expenses, and labor costs. The company plans to enhance corporate value by combining reinvestment in growth opportunities with shareholder returns through share buybacks and dividends, while simultaneously implementing revenue structure strengthening measures including price adjustments.

Priority investment areas focus on deepening presence in core markets and expanding high-value-added products. The company positions high-end product lines for physicians and nurses, along with high-performance products, as pillars of product planning, and strengthens sales promotion and marketing to stimulate replacement demand. On the product side, the company emphasizes environmental considerations and functionality, differentiating itself through initiatives such as introducing reusable surgical materials called "Comperpack" developed in partnership with a U.S. company. Quality assurance is maintained through ISO 9001 certification and environmental management through ISO 14001 certification.

For new market development, the company is accelerating overseas expansion centered on East Asia. In Taiwan, the company is expanding its business foundation through the adoption of laundry outsourcing services and establishment of a direct e-commerce sales model. In South Korea, the company plans direct market entry through the establishment of a Seoul branch. Domestically, the company aims to expand market share in adjacent segments by capturing large-scale projects, offering low-price-point products developed through global integrated strategies, and diversifying sales methods such as surgical wear leasing proposals. Through these initiatives, the company aims to achieve its sales targets and expand profitability.

The company is also focusing on technological innovation and strengthening production systems, pursuing productivity improvements through new production equipment and optimizing domestic and overseas production to accommodate diverse products in small quantities. The company manages foreign exchange risk through forward exchange contracts and maintains and reduces costs through overseas raw material procurement and optimal production locations. The company aims to ensure stable supply and continuous introduction of high-value-added products through infection control product development, adoption of environmentally responsive materials, establishment of responsive logistics systems, and strengthened internal information management.